KPV
10 mg
€ 42,00
per vialComing soonKPV — 10 mg per research vial. Supplier identity and technical documentation remain subject to verification. For laboratory research only; not for human or veterinary use.
- Reference
- MVP / 011
- Strength
- 10 mg
- Availability
- Coming soon
- Handling
- Store cool and dry, away from light. Laboratory handling only.
- Shipping
- PostNL within the Netherlands, € 4,99 per order
Specification
For research only. Not for human use.
Key research areas
- PepT1-mediated peptide transport
- NF-κB and MAP-kinase inflammatory signalling
- Intestinal epithelial biology
- Cytokine and chemokine responses
- Minimal-sequence peptide pharmacology
Potential benefits observed in research
- Reduced inflammatory-messenger production reported in cell studies.
- Attenuated intestinal inflammation observed in animal colitis models.
- Active at remarkably small size, enabling transport-mechanism research.
- Studied without the pigmentation effects associated with its parent hormone.
Reported observations from published studies under controlled conditions. They do not establish the safety, quality or performance of this research material.
Research documentation
KPV — 10 mg
KPV is a tripeptide composed of lysine, proline and valine investigated for its influence on inflammatory signalling in experimental systems. Research in intestinal epithelial and immune cells has examined uptake through PepT1, a transporter that moves small peptides into cells. In these models, investigators reported changes in NF-κB and MAP kinase signalling, pathways involved in cellular inflammatory responses, alongside altered production of inflammatory messengers. Related animal experiments have explored intestinal inflammation. KPV is scientifically distinctive because its compact three-amino-acid structure allows researchers to examine relationships between peptide transport and intracellular signalling.
Key Research Areas
- Peptide transport
- PepT1 activity
- inflammatory signalling
- intestinal epithelial biology
- cytokine responses
These preclinical findings do not establish treatment effects in people or clinical safety for the MVP research material. Original cell and animal study.
For research purposes only. Not for human consumption or therapeutic use.
